empowers people
to take life-saving decisions
ABOUT

Ghent University Hospital developed an easy to use and validated device for self-detection of acute coronary occlusion in subjects with chest discomfort based on a proprietary 3- lead ECG system and algorithm.
Self-recording with a RELF device is feasible for most patients with coronary artery disease. The sensitivity and specificity for automatic detection of the earliest phase of acute coronary artery occlusion support the concept of the RELF device for patient empowerment to reduce delay and increase survival without overloading emergency services.
PUBLICATIONS
Lancet Digital Health
VOLUME 1, ISSUE 2, PE90-E99, JUNE 01, 2019
BioVox
URL
DECEMBER 18, 2017
Liberale Mutualiteit
Liever Thuis Lm, NR 4 / 2019
Journal of Electrocardiology
VOLUME 49, P192-201, 2016
ESC Congress 2019 &
World Congress of Cardiology
31 AUGUST – 4 SEPTEMBER 2019, PARIS - FRANCE



